melphalan pharmacokinetics were studied in 20 children with stage iv neuroblastomas or ewing 's sarcomas and in 10 adults with aml , all , or small cell lung carcinomas , after iv administration of high doses ( 140 mg/m2 with furosemide-induced diuresis and 180 mg/m2 without induced diuresis ) and high fluid intake ( 3000 ml/m2/day ) .
C0025241
melphalan
C0027819
neuroblastomas